A SARS-CoV-2 nucleocapsid ELISA represents a low-cost alternative to lateral flow testing for community screening in LMI countries

Maria Victoria Humbert, Precious Chinonyerem Opurum, Nathan J. Brendish, Stephen Poole, Peijun He, Ioannis Katis, Jerry Quaye, Yaw Bediako, Patrick Jacques Duriez, Robert W. Eason, Collin Sones, Osbourne Quaye, Gordon A. Awandare, Myron Christodoulides, Tristan W. Clark, Peter K. Quashie, Christopher J. McCormick

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A SARS-CoV-2 nucleocapsid ELISA represents a low-cost alternative to lateral flow testing for community screening in LMI countries'. Together they form a unique fingerprint.

Immunology and Microbiology

Nursing and Health Professions

Biochemistry, Genetics and Molecular Biology

Agricultural and Biological Sciences

Psychology